Dirui Industrial Co Ltd Asset Resilience Ratio
Dirui Industrial Co Ltd asset resilience ratio. Dirui Industrial Co Ltd (300396) has an Asset Resilience Ratio of 3.90% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300396 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Dirui Industrial Co Ltd (2013–2025)
Asset resilience ratio of Dirui Industrial Co Ltd from 2013 to 2025. This chart shows how Dirui Industrial Co Ltd's Asset Resilience Ratio has changed over time. Read 300396 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Dirui Industrial Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Dirui Industrial Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥100.08 Million | 3.9% |
| Total Liquid Assets | CN¥100.08 Million | 3.90% |
Asset Resilience Insights
- Limited Liquidity: Dirui Industrial Co Ltd maintains only 3.90% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Dirui Industrial Co Ltd Industry Peers by Asset Resilience Ratio
Compare Dirui Industrial Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Dirui Industrial Co Ltd Asset Resilience Ratio by Year (2013–2025)
Dirui Industrial Co Ltd asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Dirui Industrial Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.50% | CN¥180.32 Million ≈ $26.39 Million |
CN¥2.77 Billion ≈ $405.64 Million |
+6.50pp |
| 2023-12-31 | 0.01% | CN¥185.85K ≈ $27.20K |
CN¥3.32 Billion ≈ $485.93 Million |
-5.83pp |
| 2022-12-31 | 5.83% | CN¥170.61 Million ≈ $24.96 Million |
CN¥2.93 Billion ≈ $428.06 Million |
-11.91pp |
| 2021-12-31 | 17.74% | CN¥421.40 Million ≈ $61.66 Million |
CN¥2.38 Billion ≈ $347.63 Million |
+13.60pp |
| 2019-12-31 | 4.14% | CN¥85.43 Million ≈ $12.50 Million |
CN¥2.06 Billion ≈ $301.78 Million |
+4.13pp |
| 2018-12-31 | 0.01% | CN¥171.21K ≈ $25.05K |
CN¥1.99 Billion ≈ $291.04 Million |
0.00pp |
| 2017-12-31 | 0.01% | CN¥212.70K ≈ $31.12K |
CN¥1.85 Billion ≈ $270.86 Million |
0.00pp |
| 2016-12-31 | 0.01% | CN¥248.03K ≈ $36.30K |
CN¥1.86 Billion ≈ $271.94 Million |
0.00pp |
| 2015-12-31 | 0.02% | CN¥274.84K ≈ $40.22K |
CN¥1.77 Billion ≈ $258.56 Million |
-5.72pp |
| 2014-12-31 | 5.73% | CN¥60.00 Million ≈ $8.78 Million |
CN¥1.05 Billion ≈ $153.17 Million |
+1.15pp |
| 2013-12-31 | 4.58% | CN¥25.00 Million ≈ $3.66 Million |
CN¥546.01 Million ≈ $79.90 Million |
-- |
About Dirui Industrial Co Ltd
Dirui Industrial Co.,Ltd. researches, develops, produces, and sells ng instruments and related reagents and test strips products in the People's Republic of China. It offers urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory solutions. The company was founded in 1992 and is hea… Read more